Reduced drug elimination in congestive heart failure
- 1 August 1978
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 65 (2) , 271-276
- https://doi.org/10.1016/0002-9343(78)90819-7
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Aminopyrine metabolism in the presence of hyperbilirubinemia due to cholestasis or hepatocellular disease; Combined use of laboratory tests to study disease‐induced alterations in drug dispositionClinical Pharmacology & Therapeutics, 1977
- Aminopyrine disposition: Studies on breath, saliva, and urine of normal subjects and patients with liver diseaseClinical Pharmacology & Therapeutics, 1976
- Aminopyrine demethylation measured by breath analysis in cirrhosisClinical Pharmacology & Therapeutics, 1976
- Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urineClinical Pharmacology & Therapeutics, 1975
- The effect of congestive heart failure on quinidine pharmacokineticsAmerican Heart Journal, 1975
- Influence of congestive heart failure on blood levels of lidocaine and its active monodeethylated metaboliteClinical Pharmacology & Therapeutics, 1975
- Assessment of Aminopyrine Metabolism in Man by Breath Analysis after Oral Administration of14C-AminopyrineNew England Journal of Medicine, 1974
- Lidocaine disposition kinetics in monkey and man; II. Effects of hemorrhage and sympathomimetic drug administrationClinical Pharmacology & Therapeutics, 1974
- The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in manAmerican Heart Journal, 1971
- Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in ManCirculation, 1971